Vaxil Bio Ltd V.VXL

Alternate Symbol(s): VXLLF

Healthcare Biotechnology

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.

TSXV:VXL - Post by User

Vaxil Bio Ltd

<< Previous

Bullboard Posts

Next >>

Post by bigbanktheoryon Apr 06, 2021 7:50am

85 Views

Post# 32940107

Blig, you're still here

I like the way you follow timelines. As for some of your posts, hmmm. Anyways, not to spam, I'm at TSF, TraceSafe. DD. I'm waiting for vxl to hopefully go a bit lower. They might have something, who knows. As for partnership's, yaddie yaddie yadda. Been hearing about that now for over a year on different sites. Glta

<< Previous

Bullboard Posts

Next >>

3 Mid-Sized Stocks to Consider This Season